Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04180020 · ClinicalTrials.gov registry record · NA
Coordinating Opioid Use Treatment Through Medical Management With Infection Treatment (Project COMMIT)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 171
- Enrollment target
NCT04180020 is a NA study that has completed, run by Yale University. The registered enrollment target is 171 participants.
The verdict
NCT04180020, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
Study Summary
This study seeks to test a new model of care (ID/LAB) in which opioid use disorder (OUD) is managed by infectious disease (ID) specialists and hospitalists concurrent with management of the OUD-related infections, using long-acting injectable buprenorphine (LAB), followed by referral as soon as possible after hospital discharge to community resources for long term treatment of OUD.
Interventions
- OTHER TAU
- OTHER ID/LAB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2020-08-18 |
| Est. Completion | 2024-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04180020
The ClinicalTrials.gov registry entry for NCT04180020 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TAU is the first listed.
NCT04180020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04180020 about?
NCT04180020 is a clinical study titled "Coordinating Opioid Use Treatment Through Medical Management With Infection Treatment (Project COMMIT)". This study seeks to test a new model of care (ID/LAB) in which opioid use disorder (OUD) is managed by infectious disease (ID) specialists and hospitalists concurrent with management of the OUD-related infections, using long-acting injectable buprenorphine (LAB), followed by referral as soon as poss...
What is the current status of trial NCT04180020?
This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2020-08-18. Estimated completion is 2024-04-25.
What interventions are being tested in trial NCT04180020?
The interventions under investigation include: TAU (OTHER), ID/LAB (OTHER).
Who is sponsoring clinical trial NCT04180020?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.